Found: 1
Select item for more details and to access through your institution.
Phase II trial of the combination of denileukin diftitox and rituximab for relapsed/refractory B-cell non-Hodgkin lymphoma.
- Published in:
- British Journal of Haematology, 2007, v. 138, n. 4, p. 502, doi. 10.1111/j.1365-2141.2007.06684.x
- By:
- Publication type:
- Article